HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giovanni Abbadessa Selected Research

alpha-Fetoproteins (alpha-Fetoprotein)

11/2016Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giovanni Abbadessa Research Topics

Disease

26Neoplasms (Cancer)
01/2024 - 01/2007
12Hepatocellular Carcinoma (Hepatoma)
12/2022 - 10/2010
5Fibrosis (Cirrhosis)
12/2022 - 01/2013
4Colorectal Neoplasms (Colorectal Cancer)
01/2015 - 07/2006
4Neoplasm Metastasis (Metastasis)
01/2013 - 01/2007
3Cholangiocarcinoma
10/2019 - 01/2016
3Neutropenia
01/2018 - 12/2011
3Disease Progression
01/2018 - 01/2013
3Breast Neoplasms (Breast Cancer)
01/2015 - 01/2012
2Multiple Myeloma
12/2023 - 11/2019
2Liver Cirrhosis (Hepatic Cirrhosis)
12/2022 - 01/2013
2Carcinogenesis
10/2020 - 10/2008
2Leukemia
10/2020 - 01/2015
2Hematologic Neoplasms (Hematological Malignancy)
10/2020 - 10/2018
2Proteus Syndrome
01/2019 - 01/2017
2Abdominal Pain (Pain, Abdominal)
01/2018 - 10/2010
1Melanoma (Melanoma, Malignant)
01/2024
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/2023
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2023
1Lymphoma (Lymphomas)
02/2023
1Hodgkin Disease (Hodgkin's Disease)
02/2023
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2020
1Rare Diseases (Rare Disease)
01/2019
1Carcinoma (Carcinomatosis)
01/2019
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2018
1Liver Failure
01/2018
1Acute Coronary Syndrome
01/2018
1Ascites
01/2018
1Sepsis (Septicemia)
01/2018
1Acute Kidney Injury (Acute Renal Failure)
01/2018
1Craniosynostoses (Craniosynostosis)
12/2017
1LEOPARD Syndrome (Syndrome, LEOPARD)
01/2017
1Hypertrophy
01/2017
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2017
1Sickle Cell Anemia (Hemoglobin S Disease)
01/2017
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2017
1Endometrial Neoplasms (Endometrial Cancer)
01/2017
1Osteolysis
01/2012
1Leukopenia
12/2011
1Vomiting
12/2011
1Thrombocytopenia (Thrombopenia)
12/2011
1Dehydration (Water Stress)
12/2011
1Anorexia
10/2010

Drug/Important Bio-Agent (IBA)

9Sorafenib (BAY 43-9006)FDA Link
12/2022 - 05/2011
9ARQ 197IBA
01/2018 - 12/2011
7MiransertibIBA
01/2019 - 01/2015
5derazantinibIBA
10/2019 - 01/2016
4Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2016
4isatuximabIBA
12/2023 - 01/2022
3cemiplimabIBA
01/2024 - 01/2022
3Tyrosine Kinase InhibitorsIBA
10/2020 - 04/2017
2Diethylnitrosamine (N-Nitrosodiethylamine)IBA
12/2022 - 02/2018
2AntibodiesIBA
01/2022 - 11/2019
2ibrutinibIBA
10/2020 - 10/2018
2Phosphotransferases (Kinase)IBA
10/2020 - 01/2016
2Agammaglobulinaemia Tyrosine KinaseIBA
10/2020 - 10/2018
2Proteins (Proteins, Gene)FDA Link
10/2020 - 01/2007
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2019 - 01/2016
2Paclitaxel (Taxol)FDA LinkGeneric
04/2017 - 01/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2016 - 01/2007
2Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2007 - 07/2006
1Transforming Growth Factor beta (TGF-beta)IBA
01/2024
1Programmed Cell Death 1 ReceptorIBA
02/2023
1Thomsen-Friedenreich antibodiesIBA
01/2022
1B7-H1 AntigenIBA
01/2022
1Tyrosine (L-Tyrosine)FDA Link
10/2020
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2020
1RNA (Ribonucleic Acid)IBA
10/2020
1ARQ531IBA
10/2020
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
10/2019
1Therapeutic UsesIBA
01/2019
1Carboplatin (JM8)FDA LinkGeneric
04/2017
1IntegrinsIBA
01/2017
1Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA
01/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2017
1Aligeron (AS 2)IBA
01/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017
1Hydroxyurea (Hydrea)FDA LinkGeneric
01/2017
1P-SelectinIBA
01/2017
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
11/2016
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2016
1Methylnitronitrosoguanidine (MNNG)IBA
11/2016
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2016
1Adenosine Triphosphate (ATP)IBA
01/2016
1Zoledronic Acid (Zometa)FDA Link
01/2013
1Small Interfering RNA (siRNA)IBA
01/2012

Therapy/Procedure

11Therapeutics
01/2022 - 12/2011
3Drug Therapy (Chemotherapy)
01/2022 - 07/2006
1Injections
12/2022
1Castration
01/2022
1Immunotherapy
01/2022
1Organ Transplantation
11/2019
1Precision Medicine
01/2019
1Investigational Therapies (Experimental Therapy)
04/2017
1Oral Administration
01/2017
1Drug Tapering
05/2011